# Effects of Somatostatin on Post-endoscopic Portal Hemodynamic in Cirrhotic Patients With Esophageal Gastric Varices

> **NCT01426087** · NA · UNKNOWN · sponsor: **Yunsheng Yang** · enrollment: 126 (estimated)

## Conditions studied

- Esophageal Varices Secondary to Cirrhosis of Liver

## Interventions

- **DRUG:** Somatostatin
- **PROCEDURE:** endoscopic therapy

## Key facts

- **NCT ID:** NCT01426087
- **Lead sponsor:** Yunsheng Yang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2011-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426087, "Effects of Somatostatin on Post-endoscopic Portal Hemodynamic in Cirrhotic Patients With Esophageal Gastric Varices". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01426087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*